Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsy
BackgroundThe Montreal Cognitive assessment (MoCA) is a well-validated global cognitive screening instrument. Its validity in progressive supranuclear palsy (PSP) has not been assessed.ObjectivesTo evaluate the MoCA as an outcome measure in PSP clinical trials.MethodsCognitive data from 162 particip...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2024-12-01
|
| シリーズ: | Frontiers in Neurology |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1501206/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
